ArticleJournal of cheminformatics2026
How quantum-chemical geometry optimization level affects classical 3D descriptors and QSAR performance: a comparative study.
Article in Journal of cheminformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Accurate representation of three-dimensional (3D) molecular structures is essential for quantitative structure-activity relationship (QSAR) modeling; however, it remains unclear whether increasing the level of theory used for quantum-chemical geometry optimization yields a practically meaningful benefit for classical conformation-dependent 3D descriptors (Dragon 3D) and the resulting QSAR performance. Here, we benchmark eight commonly used quantum-chemical (QM) geometry-optimization protocols-from minimal-basis Hartree-Fock (HF/STO-3 G) to def2-based hybrid density functional theory (DFT) and the composite method r
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.